ZBH
Stock Details
ZBH is Zimmer Biomet Holdings, Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 111.02$. Average daily volumn in 3 months 1.05M. Market cap 23.37B
Stock symbol : ZBH. Exchange : NYSE. Currency : USD Lastest price : 111.39$. Total volume : 597.09k. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Zimmer Biomet Holdings, Inc. (ZBH)
Last Price
111.39$Change
4.07Volume
597.09k
| Previous Close | 107.32 |
| Open | 109.17 |
| Day Range | 109.34-111.75 |
| Bid | 111.37 x 900 |
| Ask | 111.40 x 1k |
| Volume | 597.09k |
| Average Volume | 1.05M |
| Market Cap | 23.37B |
| Beta | 1.14 |
| 52 Week Range | 100.39-147.43 |
| Trailing P/E | 80.72 |
| Foward P/E | 15.62 |
| Dividend (Yield %) | 0.92% |
| Ex-Dividend Date | 2022-09-29 |
Financial Details
Organization
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconst... ruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Market Cap:
23.37BRevenue:
7.84BTotal Assets:
23.46BTotal Cash:
478.5M
News about "Zimmer Biomet Holdings, Inc."
New Mexico Educational Retirement Board Trims Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Source from : Defense World - 16 hours ago
New Mexico Educational Retirement Board cut its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Rating) by 4.1% during the second quarter, according to its most recent 13F filing with the ...See details»
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by DAVENPORT & Co LLC
Source from : Defense World - 2 days ago
DAVENPORT & Co LLC lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Rating) by 4.6% in the second quarter, according to its most recent filing with the Securities and ...See details»
Zimmer Biomet Holdings Inc.
Source from : Wall Street Journal - 4 days ago
1 Day ZBH -2.40% DJIA -1.71% S&P 500 -1.51% Health Care/Life Sciences 0.39% Bryan C. Hanson Chairman, President & Chief Executive Officer Advanced Medical Technology Association, Zimmer Biomet ...See details»
Are Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Mixed Financials Driving The Negative Sentiment?
Source from : Nasdaq - 29 days ago
Zimmer Biomet Holdings' Earnings Growth And 2.4% ROE As ... of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...See details»
Regenerative Medicine Market Future is Going Big on Constant R&D, Analyst Says
Source from : Medgadget - 1 days ago
The outbreak of the pandemic has had a positive impact on the global regenerative medicine market. For instance, in 2020, Singapore based Duke-NUS medical school’s emerging infectious disease program ...See details»
Zimmer Biomet Receives FDA Clearance for Identity™ Shoulder System for Shoulder Replacement
Source from : Business Insider - 14 days ago
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Identity™ Shoulder System for ...See details»
USD 155.43 Bn Growth in Medical Devices Market Size, Majority of Market Growth to Originate from North America - Technavio
Source from : Yahoo - 1 days ago
Stryker Corp., and Zimmer Biomet Holdings Inc. The report also covers the following areas: Medical Devices Market size Medical Devices Market trends Medical Devices Market industry analysis Viral Pet ...See details»
Software Glitch Prompts a Medical Device Recall for Zimmer Biomet
Source from : Design News - 16 days ago
The latest example of this trend is Zimmer Biomet's recall of the Rosa One 3.1 Brain Application. FDA recently flagged the recall, which was initiated in late September. The agency said a software ...See details»
The Global Medical Devices Market is expected to grow by $155.43 bn during 2022-2026, accelerating at a CAGR of 5.5% during the forecast period
Source from : Benzinga.com - 1 days ago
Reportlinker.com announces the release of the report "Global Medical Devices Market 2022-2026" - 5% during the ...See details»
Zimmer Biomet places mixed reality in the surgical suite
Source from : INside INdiana Business - 5 days ago
Science fiction is joining real-world technology in the “Orthopedic Capital of the World,” with hologram technology for hip implant surgery.See details»
The Best Stock in Indiana: Zimmer Biomet
Source from : Kiplinger - 22 days ago
The company that resulted from the 2015 merger of Zimmer and smaller competitor Biomet is the leading maker of orthopedic implants, such as knee and hip replacements, for the U.S., Europe and Japan.See details»
Why this biotech company has years of growth ahead
Source from : MoneyWeek - 28 days ago
The leader in the worldwide market for hip and knee joints is Zimmer Biomet (NYSE: ZBH), with 33% of the market, followed by Stryker with 22%. The UK’s Smith & Nephew is in fourth place with 11%.See details»
Zimmer Biomet's Smart Knee: A Surgeon's Perspective
Source from : MD&M East - 7 days ago
According to a report from BTIG's Ryan Zimmerman, Yergler is among the earliest adopters of Persona IQ, Zimmer Biomet's recently-launched "smart knee" implant, with more than 200 procedures already ...See details»
Orthobiologics Market Share, Size, Growth, Future Trends, Key Players and Industry Analysis 2022-2028
Source from : MarketWatch - 5 days ago
The scope of the report includes a detailed study of global and regional markets on Global Orthobiologics Market with the reasons given for variations in ...See details»